文献速递骨软组织肉瘤与黑色素瘤

薄层(T1)黑色素瘤局部、区域及远处复发预测列线图的开发与验证

Development and Validation of Nomograms to Predict Local, Regional, and Distant Recurrence in Patients With Thin (T1) Melanomas.
PubMed 文献 · J Clin Oncol · 2021-02-18

该研究基于荷兰人群队列(n=25,930)和澳大利亚治疗中心队列(n=2,968),开发并外部验证了预测薄层黑色素瘤(T1,≤1.0 mm)局部、区域和远处无复发生存(RFS)的列线图。列线图区分度良好,C统计量高于仅含T分期和哨兵淋巴结状态的模型,校准曲线显示预测与观察复发率匹配良好。

要点

  • 薄层黑色素瘤总体预后良好,但部分患者仍出现复发。
  • 列线图可较准确识别高危亚组,区分度优于AJCC分期参数模型。
  • 在线计算器已提供,便于临床个体化风险评估。

核心结论

  • 列线图能准确识别薄层黑色素瘤复发高危亚组,区分度优于仅含T分期和哨兵淋巴结状态的模型。

研究设计与样本

  • 荷兰人群队列(n=25,930)为开发集,澳大利亚黑色素瘤治疗中心队列(n=2,968)为验证集;中位随访分别为6.7年和12.0年。
  • 采用多变量Cox模型分别构建局部、区域和远处无复发生存(RFS)列线图。

主要发现

  • 荷兰队列局部、区域、远处复发分别为209例(0.8%)、503例(1.9%)、203例(0.8%)。
  • 澳大利亚队列局部、区域、远处复发分别为23例(0.8%)、61例(2.1%)、75例(2.5%)。
  • 开发模型C统计量:局部RFS 0.79(95%CI 0.75-0.82),区域RFS 0.77(95%CI 0.75-0.78),远处RFS 0.80(95%CI 0.77-0.83)。
  • 外部验证C统计量:局部RFS 0.80(95%CI 0.69-0.90),区域RFS 0.76(95%CI 0.70-0.82),远处RFS 0.74(95%CI 0.69-0.80)。

关键数值与推荐

  • 校准图显示预测复发率与观察复发率匹配良好。
  • 与仅含T分期和哨兵淋巴结状态的模型相比,列线图C统计量在开发队列提高9%-12%,验证队列提高11%-15%。
  • 列线图将风险评分最低和最高5%分别定义为低危和高危组。

临床怎么用

  • 列线图可用于薄层黑色素瘤患者的个体化复发风险评估,辅助识别高危患者。
  • 在线计算器(www.melanomarisk.org.au)已提供,便于临床便捷使用。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: Although the prognosis of patients with thin primary cutaneous melanomas (T1, ≤ 1.0 mm) is generally excellent, some develop recurrence. We sought to develop and validate a model predicting recurrences in patients with thin melanomas. METHODS: A Dutch population-based cohort (n = 25,930, development set) and a cohort from an Australian melanoma treatment center (n = 2,968, validation set) were analyzed (median follow-up 6.7 and 12.0 years, respectively). Multivariable Cox models were generated for local, regional, and distant recurrence-free survival (RFS). Discrimination was assessed using Harrell's C-statistic for each outcome. Each nomogram performance was evaluated using calibration plots defining low-risk and high-risk groups as the lowest and top 5% of the nomogram risk score, respectively. The nomograms' C-statistics were compared with those of a model including the current American Joint Committee on Cancer staging parameters (T-stage and sentinel node status). RESULTS: Local, regional, and distant recurrences were found in 209 (0.8%), 503 (1.9%), and 203 (0.8%) Dutch patients, respectively, and 23 (0.8%), 61 (2.1%), and 75 (2.5%) Australian patients, respectively. C-statistics of 0.79 (95% CI, 0.75 to 0.82) for local RFS, 0.77 (95% CI, 0.75 to 0.78) for regional RFS, and 0.80 (95% CI, 0.77 to 0.83) for distant RFS were obtained for the development model. External validation showed C-statistics of 0.80 (95% CI, 0.69 to 0.90), 0.76 (95% CI, 0.70 to 0.82), and 0.74 (95% CI, 0.69 to 0.80), respectively. Calibration plots showed a good match between predicted and observed rates. Using the nomogram, the C-statistic was increased by 9%-12% for the development cohort and by 11%-15% for the validation cohort, compared with a model including only T-stage and sentinel node status. CONCLUSION: Most patients with thin melanomas have an excellent prognosis, but some develop recurrence. The presented nomograms can accurately identify a subgroup at high risk. An online calculator is available at www.melanomarisk.org.au.

来源:J Clin Oncol,查看原文。版权归原作者所有。

引用

  1. El Sharouni MA, Ahmed T, Varey AHR, et al. Development and Validation of Nomograms to Predict Local, Regional, and Distant Recurrence in Patients With Thin (T1) Melanomas. J Clin Oncol. 2021. PMID: 33600211. doi:10.1200/JCO.20.02446

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。